We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Lower Dose of Regeneron’s COVID-19 Antibody Cocktail
FDA Approves Lower Dose of Regeneron’s COVID-19 Antibody Cocktail
Regeneron Pharmaceuticals has received an updated Emergency Use Authorization (EUA) from the FDA for a lower dosage of its COVID-19 antibody cocktail, REGEN-COV (casirivimab/imdevimab).